Anti-tumor mechanism of a dietary and herbal mixture
饮食和草药混合物的抗肿瘤机制
基本信息
- 批准号:6818852
- 负责人:
- 金额:$ 25.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-15 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:alternative medicineangiogenesisapoptosisbiological signal transductionbiotherapeutic agentcell growth regulationdietary supplementsdisease /disorder modelenzyme activityhistopathologylaboratory mousemalemetastasismethanolneoplasm /cancer invasivenessneoplasm /cancer nutrition therapyneoplastic cellneoplastic growthnonhuman therapy evaluationnutrition aspect of cancernutrition related tagplant extractsprotein tyrosine kinasesmall cell lung cancervegetables
项目摘要
DESCRIPTION (provided by applicant)
Recently a "Selected Vegetable and Herbal Mix (SV)" was shown to prolong the median survival time (MST) of advanced non-small cell lung cancer (NSCLC) patients 3-fold compared to controls in two small scale phase 1/11clinical trials. Initial laboratory animal study using the L1 lung adenocarcinoma model in BALB/c mice showed that combination of two of the active ingredients of SV was able to inhibit up to 80% of the tumor growth. The SV consists of a mixture of whole plants extracts solely from natural, commonly available vegetables and plants that have long been used in herbal medicine. The ingredients of SV were selected for their known anti-viral, anti-tumor and immune enhancing activities. The hypothesis is that the combined biochemical and biological effects of those active molecules are able to endow one with enhanced immune and tumor suppressive activities. The objectives of this proposal are to compare the anti-tumor efficacy of SV and its water or methanol extracts (SVE) and to elucidate the cellular and molecular mechanism for their anti-tumor effect. The specific aims are: 1) to examine the anti-tumor efficacy of SV and its extracts; 2) to investigate the effect of SV and its extracts on tumor development at cellular level and in various histopathological properties and 3) to examine the effect of SV and its extracts on molecular signaling pathways regulating growth and apoptosis of normal and tumor cells. The L1-BALB/c model will be used to explore the effect of SV and its extracts on tumor cell growth, apoptosis, metastasis and angiogenesis, as well as to identify molecular basis for the anti-tumor effect of SV. Various signaling pathways and molecules regulating the growth and apoptosis of normal and tumor cells will be examined in control and SV treated mice. SV is a safe, non-toxic dietary mixture that can be taken concurrently with other cancer therapeutic regimens. This study shall provide information for optimizing the preparation and formulation of SV and to identify its most significant anti-tumor activities that could reveal potential targets for further development or improvement of anti-tumor agents. The results could also lead to the development of in vitro assays for quality control of the SV preparation. As an anti-cancer food supplement, although the efficacy of SV has so far been shown mainly in the NSCLC patients, based upon its designed anti-tumor and immune enhancing activities, it is anticipated that SV should have a wide spectrum of anti-tumor efficacy
描述(由申请人提供)
最近,与两项小规模1/11临床试验中的对照组相比,最近显示出一种“选定的蔬菜和草药混合物(SV)”,可延长晚期非小细胞肺癌(NSCLC)患者的中位生存时间(MST)3倍。在BALB/C小鼠中使用L1肺腺癌模型的最初实验室动物研究表明,SV的两种活性成分的组合能够抑制多达80%的肿瘤生长。 SV由整个植物提取物的混合物组成,仅来自长期用于草药的天然,常用的蔬菜和植物。 SV的成分被选择用于其已知的抗病毒,抗肿瘤和免疫增强活性。假设是,这些活性分子的生化和生物学效应共同能够赋予免疫和肿瘤抑制活性增强的生化和生物学作用。该提案的目标是比较SV及其水或甲醇提取物(SVE)的抗肿瘤功效,并阐明细胞和分子机制的抗肿瘤作用。具体目的是:1)检查SV及其提取物的抗肿瘤功效; 2)研究SV及其提取物对细胞水平和各种组织病理学特性的肿瘤发育的影响; 3)检查SV及其提取物对调节正常和肿瘤细胞生长和凋亡的分子信号通路的影响。 L1-BALB/C模型将用于探索SV及其提取物对肿瘤细胞生长,凋亡,转移和血管生成的作用,并确定SV抗肿瘤作用的分子基础。调节正常细胞和肿瘤细胞生长和凋亡的各种信号通路和分子将在对照和SV处理的小鼠中检查。 SV是一种安全的,无毒的饮食混合物,可以与其他癌症治疗方案同时服用。这项研究应提供用于优化SV制备和制定的信息,并确定其最重要的抗肿瘤活性,这些活动可能揭示了进一步开发或改善抗肿瘤药物的潜在目标。结果还可能导致开发体外测定法,以控制SV制备的质量控制。作为一种抗癌食品补充剂,尽管迄今为止SV的功效主要在NSCLC患者中显示在其设计的抗肿瘤和免疫增强活动中,但预计SV应该具有广泛的抗肿瘤功效。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LU-HAI WANG其他文献
LU-HAI WANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LU-HAI WANG', 18)}}的其他基金
Anti-tumor mechanism of a dietary and herbal mixture
饮食和草药混合物的抗肿瘤机制
- 批准号:
6947926 - 财政年份:2004
- 资助金额:
$ 25.43万 - 项目类别:
CELL TRANSFORMATION BY INSULIN AND IGF1 RECEPTORS
胰岛素和 IGF1 受体的细胞转化
- 批准号:
2470509 - 财政年份:1992
- 资助金额:
$ 25.43万 - 项目类别:
CELL TRANSFORMATION BY INSULIN AND IGF1 RECEPTORS
胰岛素和 IGF1 受体的细胞转化
- 批准号:
2837652 - 财政年份:1992
- 资助金额:
$ 25.43万 - 项目类别:
CELL TRANSFORMATION BY INSULIN AND IGFI RECEPTORS
胰岛素和 IGFI 受体的细胞转化
- 批准号:
3199489 - 财政年份:1992
- 资助金额:
$ 25.43万 - 项目类别:
CELL TRANSFORMATION BY INSULIN AND IGFI RECEPTORS
胰岛素和 IGFI 受体的细胞转化
- 批准号:
2096289 - 财政年份:1992
- 资助金额:
$ 25.43万 - 项目类别:
CELL TRANSFORMATION BY INSULIN AND IGFI RECEPTORS
胰岛素和 IGFI 受体的细胞转化
- 批准号:
2096288 - 财政年份:1992
- 资助金额:
$ 25.43万 - 项目类别:
CELL TRANSFORMATION BY INSULIN AND IGFI RECEPTORS
胰岛素和 IGFI 受体的细胞转化
- 批准号:
2096287 - 财政年份:1992
- 资助金额:
$ 25.43万 - 项目类别:
CELL TRANSFORMATION BY INSULIN AND IGF1 RECEPTORS
胰岛素和 IGF1 受体的细胞转化
- 批准号:
6475785 - 财政年份:1992
- 资助金额:
$ 25.43万 - 项目类别:
CELL TRANSFORMATION BY INSULIN AND IGF1 RECEPTORS
胰岛素和 IGF1 受体的细胞转化
- 批准号:
6124613 - 财政年份:1992
- 资助金额:
$ 25.43万 - 项目类别:
相似国自然基金
地黄梓醇协控缺血脑区血管-神经新生偶联机制
- 批准号:81873034
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
DJ-1/FGFR1信号通路参与肝细胞癌索拉非尼耐药的机制研究
- 批准号:81602626
- 批准年份:2016
- 资助金额:16.0 万元
- 项目类别:青年科学基金项目
Polo样激酶2在抑制胶质瘤细胞增殖及血管生成中的作用及机制研究
- 批准号:81660421
- 批准年份:2016
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
虫草素及甘草素定向合成产物促人肝癌细胞凋亡调控机制研究
- 批准号:81402955
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
应激在子宫内膜异位症发生发展中的作用
- 批准号:81471434
- 批准年份:2014
- 资助金额:74.0 万元
- 项目类别:面上项目
相似海外基金
Mechanisms of prostate cancer prevention by Korean Angelica
韩国当归预防前列腺癌的机制
- 批准号:
9044040 - 财政年份:2012
- 资助金额:
$ 25.43万 - 项目类别:
Mechanisms of prostate cancer prevention by Korean Angelica
韩国当归预防前列腺癌的机制
- 批准号:
8700324 - 财政年份:2012
- 资助金额:
$ 25.43万 - 项目类别:
Mechanistic Studies on Prostate Cancer Prevention by Gugulipid
古古脂预防前列腺癌的机制研究
- 批准号:
8712195 - 财政年份:2012
- 资助金额:
$ 25.43万 - 项目类别:
Mechanisms of prostate cancer prevention by Korean Angelica
韩国当归预防前列腺癌的机制
- 批准号:
8547743 - 财政年份:2012
- 资助金额:
$ 25.43万 - 项目类别:
Mechanisms of prostate cancer prevention by Korean Angelica
韩国当归预防前列腺癌的机制
- 批准号:
8368398 - 财政年份:2012
- 资助金额:
$ 25.43万 - 项目类别: